Mutational analysis of a function of xeroderma pigmentosum group A (XPA) protein in strand-specific DNA repair. 1998

T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
Institute for Molecular and Cellular Biology, Osaka University, 1-3 Yamadaoka, Suita, Osaka 565-0871, Japan.

To analyze the function of the xeroderma pigmentosum group A (XPA) protein in strand-specific DNA repair, we examined repair of UV-induced cyclobutane pyrimidine dimer (CPD) in transcribed and non-transcribed strands of the dihydrofolate reductase gene of xeroderma pigmentosum group A (XP-A) cell line (XP12ROSV) which was transfected with various types of mutant XPA cDNA. The transfectant overexpressing mutant XPA with a defect in the interaction with either ERCC1, replication protein A (RPA), or general transcription factor TFIIH, showed more or less decreased repair of CPD in each strand in parallel, while in the transfectant overexpressing R207G (Arg207to Gly) mutant XPA derived from XP129, a UV-resistant XP12ROSV revertant, the rate of CPD repair was almost normal in each strand. We also examined the dose responses of the XPA protein on CPD repair in each strand by the modulation of the expression levels of wild-type or R207G mutant XPA using an inducible expression system, LacSwitchtrade mark promoter. There were good correlations between the rate of CPD repair in each strand and the amount of XPA protein produced in these Lac cells. Our results indicate that the XPA protein is equally important for the CPD repair in both transcribed and non-transcribed strands and that the R207G mutation found in XP129 may not be responsible for a selective defect in CPD repair in the non-transcribed strand in XP129.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011740 Pyrimidine Dimers Dimers found in DNA chains damaged by ULTRAVIOLET RAYS. They consist of two adjacent PYRIMIDINE NUCLEOTIDES, usually THYMINE nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers block DNA REPLICATION. Cyclobutane Pyrimidine Dimer,Cyclobutane-Pyrimidine Dimer,Cytosine-Thymine Dimer,Pyrimidine Dimer,Thymine Dimer,Thymine Dimers,Cyclobutane-Pyrimidine Dimers,Cytosine-Thymine Dimers,Thymine-Cyclobutane Dimer,Thymine-Thymine Cyclobutane Dimer,Cyclobutane Dimer, Thymine-Thymine,Cyclobutane Dimers, Thymine-Thymine,Cyclobutane Pyrimidine Dimers,Cytosine Thymine Dimer,Cytosine Thymine Dimers,Pyrimidine Dimer, Cyclobutane,Pyrimidine Dimers, Cyclobutane,Thymine Cyclobutane Dimer,Thymine Thymine Cyclobutane Dimer,Thymine-Cyclobutane Dimers,Thymine-Thymine Cyclobutane Dimers
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013762 Tetrahydrofolate Dehydrogenase An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. (Dorland, 27th ed) EC 1.5.1.3. Dihydrofolate Dehydrogenase,Dihydrofolate Reductase,Folic Acid Reductase,Acid Reductase, Folic,Dehydrogenase, Dihydrofolate,Dehydrogenase, Tetrahydrofolate,Reductase, Dihydrofolate,Reductase, Folic Acid

Related Publications

T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
April 1996, Acta paediatrica (Oslo, Norway : 1992),
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
May 2002, The Journal of biological chemistry,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
October 2008, The Journal of biological chemistry,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
July 1995, Carcinogenesis,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
February 1981, Fortschritte der Medizin,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
October 2017, Journal of medicinal chemistry,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
October 2010, Proceedings of the National Academy of Sciences of the United States of America,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
June 1992, The Journal of biological chemistry,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
March 1991, Biochemical and biophysical research communications,
T Kobayashi, and S Takeuchi, and M Saijo, and Y Nakatsu, and H Morioka, and E Otsuka, and M Wakasugi, and O Nikaido, and K Tanaka
September 1996, Cell,
Copied contents to your clipboard!